|
UPF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.57790497019073E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.27399979454879E-10 |
| Normal-vs-Stage2 |
8.37129999999853E-05 |
| Normal-vs-Stage3 |
2.31589999999393E-05 |
| Normal-vs-Stage4 |
4.74080000001376E-06 |
| Stage1-vs-Stage2 |
9.283800E-01 |
| Stage1-vs-Stage3 |
2.103000E-01 |
| Stage1-vs-Stage4 |
9.469800E-01 |
| Stage2-vs-Stage3 |
3.670600E-01 |
| Stage2-vs-Stage4 |
9.830800E-01 |
| Stage3-vs-Stage4 |
3.486000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.18520012984902E-10 |
| Normal-vs-AfricanAmerican |
5.806000E-04 |
| Normal-vs-Asian |
1.4659000002748E-07 |
| Caucasian-vs-AfricanAmerican |
3.583400E-01 |
| Caucasian-vs-Asian |
1.772020E-01 |
| AfricanAmerican-vs-Asian |
9.428800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.58199947270555E-10 |
| Normal-vs-Female |
1.15109999310192E-09 |
| Male-vs-Female |
2.224400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.8569002719081E-10 |
| Normal-vs-Age(41-60Yrs) |
2.42230002722721E-09 |
| Normal-vs-Age(61-80Yrs) |
9.89919999999644E-05 |
| Normal-vs-Age(81-100Yrs) |
2.914000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.018200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.134400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.338200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.243800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.109000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.246600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.82932999999164E-05 |
| Classical-VS-Follicular |
8.003600E-04 |
| Classical-VS-Other |
7.828000E-01 |
| Classical-VS-Normal |
1.44662060108658E-13 |
| Tall-VS-Follicular |
3.420600E-01 |
| Tall-VS-Other |
8.304200E-02 |
| Tall-VS-Normal |
5.078300E-02 |
| Follicular-VS-Other |
4.450400E-01 |
| Follicular-VS-Normal |
4.344500E-03 |
| Other-VS-Normal |
4.103900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.04360003866577E-09 |
| Normal-vs-N1 |
1.769790E-04 |
| N0-vs-N1 |
6.804000E-01 |
|
|
